Choroidal Neovascularization (CNV) Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Choroidal Neovascularization (CNV) Market
Choroidal Neovascularization (CNV) Market: By Treatment Type (Angiogenesis Inhibitors Injection, Photodynamic Therapy, Surgery), By Diagnosis Types & By Geography- Forecast (2018- 2023)
Report Code : HCR 0119
Updated Date: 10 May, 2018  

1. Choroidal Neovascularization (CNV) Market Overview 
2. Executive Summary  
3. Choroidal Neovascularization (CNV) Market Landscape 
   3.1. Market Share Analysis 
   3.2. Comparative Analysis 
      3.2.1. End-User Profiling 
      3.2.2. Patent Analysis 
      3.2.3. Financial Analysis of Top 5 Players 
4. Choroidal Neovascularization (CNV) Market Forces 
   4.1. Market Drivers 
   4.2. Market Constraints 
   4.3. Market Challenges  
   4.4. Attractiveness of Industry  
      4.4.1. Power of Supplier 
      4.4.2. Power of Consumer 
      4.4.3. Threat of New Entrants 
      4.4.4. Threat of Substitution 
      4.4.5. Degree of Competition 
5. Choroidal Neovascularization (CNV) Market Strategic Analysis 
   5.1. Value Chain Analysis 
   5.2. Pricing Analysis  
   5.3. Opportunity Analysis 
   5.4. Product Life Cycle Analysis  
   5.5. Suppliers & Distributors 
6. Choroidal Neovascularization (CNV) Market Analysis - By Treatment Type 
   6.1. Angiogenesis Inhibitors Injection 
   6.2. Photodynamic Therapy 
   6.3. Laser photocoagulation 
   6.4. Low-dose Radiation Therapy 
   6.5. Surgery 
7. Choroidal Neovascularization (CNV) Market Analysis- By Type of Diagnosis 
   7.1. Fluorescein angiography (FA) 
   7.2. Indocyanine green (ICG) angiography 
   7.3. Spectral domain optical coherence tomography (OCT) 
   7.4. Others 
8. Choroidal Neovascularization (CNV) Market Analysis- By Geography 
   8.1. North America 
      8.1.1. The U.S. 
      8.1.2. Canada 
      8.1.3. Rest of North America 
   8.2. Europe 
      8.2.1. The U.K. 
      8.2.2. Germany 
      8.2.3. France 
      8.2.4. Spain 
      8.2.5. Italy 
      8.2.6. Rest of Europe 
   8.3. Asia-Pacific 
      8.3.1. China 
      8.3.2. India 
      8.3.3. Japan 
      8.3.4. Australia 
      8.3.5. Rest of APAC 
   8.4. Latin America 
      8.4.1. Brazil 
      8.4.2. Argentina 
      8.4.3. Mexico 
      8.4.4. Rest of Latin America 
   8.5. Rest of the World 
      8.5.1. The Middle East 
      8.5.2. Africa 
9. Choroidal Neovascularization (CNV) Market Entropy 
   9.1. New Product Launches 
   9.2. M&As, Collaborations, Partnerships & JVs 
10. Company Profiles (Overview, Financials, Products & Services, Recent Developments, Competitors & Customers) 
   10.1. Pfizer Inc. 
   10.2. F. Hoffmann-La Roche Ltd. 
   10.3. Novartis AG 
   10.4. Regeneron Pharmaceuticals Inc. 
   10.5. Bayer AG 
   10.6. QLT Inc. 
   10.7. Sanwa Kagaku Kenkyusho Co. Ltd. 
   10.8. Promedior Inc. 
   10.9. Valeant Pharmaceuticals International Inc. 
   10.10. Gilead Sciences Inc 
*More than 10 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix 
   11.1. Abbreviations 
   11.2. Sources 
   11.3. Research Methodology 
   11.4. Bibliography 
   11.5. Compilation of Expert Insights 
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll